![]() 米国 肝疾患治療薬市場レポート・予測 2021-2027年United States Liver Medicine Market Report & Forecast 2021-2027 当レポートでは、米国における肝臓内科の市場規模および予測を掲載しています。 米国の肝臓薬市場の収益、2016-2021年、2022-2027年、(百万ドル) 2020年におけるアメリカ合衆国の肝疾患治療薬の上位5社(%) 肝... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー当レポートでは、米国における肝臓内科の市場規模および予測を掲載しています。米国の肝臓薬市場の収益、2016-2021年、2022-2027年、(百万ドル) 2020年におけるアメリカ合衆国の肝疾患治療薬の上位5社(%) 肝臓薬の世界市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに成長すると予想され、2021-2027年の間にXX%のCAGRで成長すると予想されます。 米国の肝臓薬市場は、2020年にXX百万米ドル、2027年にXX百万米ドルに達すると予測され、予測期間中にXX%のCAGRで成長すると予測されています。 QYResearchは、この業界について、収益、需要、製品タイプ、最近の開発と計画、業界動向、ドライバー、課題、障害、潜在的なリスクなどを含む、肝臓薬企業と業界専門家を調査しました。 セグメント別の総市場。 米国の肝臓薬市場、タイプ別、2016-2021年、2022-2027年(単位:百万ドル) 米国肝臓薬市場セグメント別割合、タイプ別、2020年(%) 錠剤 カプセル 経口液剤 米国の肝臓薬市場、用途別、2016-2021年、2022-2027年(単位:百万ドル) 米国肝疾患治療薬市場セグメント別割合、アプリケーション別、2020年(%) 病院 薬局 その他 競合他社の分析 本レポートでは、以下のような主要な市場参加者の分析も行っています。 主要企業の米国市場における肝臓薬の収益、2016-2021年(推定)、(百万ドル) 米国市場における主要企業の肝疾患治療薬の収益シェア、2020年(%) さらに、本レポートでは、市場における競合他社のプロファイルを紹介しています。 ファイザー ロシュ サノフィ ノバルティス アムジェン Xiuzheng Pharmaceutical Group シャオリン・ジヤオ 河南林頻製薬 Kuihua yaoye 三九製薬 ハルビン製薬グループ 目次1 Introduction to Research & Analysis Reports1.1 Liver Medicine Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Liver Medicine Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Liver Medicine Overall Market Size 2.1 United States Liver Medicine Market Size: 2021 VS 2027 2.2 United States Liver Medicine Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Liver Medicine Players in United States Market 3.2 Top United States Liver Medicine Companies Ranked by Revenue 3.3 United States Liver Medicine Revenue by Companies 3.4 Top 3 and Top 5 Liver Medicine Companies in United States Market, by Revenue in 2020 3.5 Companies Liver Medicine Product Type 3.6 Tier 1, Tier 2 and Tier 3 Liver Medicine Players in United States Market 3.6.1 List of Tier 1 Liver Medicine Companies in United States 3.6.2 List of Tier 2 and Tier 3 Liver Medicine Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Liver Medicine Market Size Markets, 2021 & 2027 4.1.2 Tablet 4.1.3 Capsule 4.1.4 Oral Liquid 4.2 By Type - United States Liver Medicine Revenue & Forecasts 4.2.1 By Type - United States Liver Medicine Revenue, 2016-2021 4.2.2 By Type - United States Liver Medicine Revenue, 2022-2027 4.2.3 By Type - United States Liver Medicine Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Liver Medicine Market Size, 2021 & 2027 5.1.2 Hospital 5.1.3 Pharmacy 5.1.4 Others 5.2 By Application - United States Liver Medicine Revenue & Forecasts 5.2.1 By Application - United States Liver Medicine Revenue, 2016-2021 5.2.2 By Application - United States Liver Medicine Revenue, 2022-2027 5.2.3 By Application - United States Liver Medicine Revenue Market Share, 2016-2027 6 Liver Medicine Companies Profiles 6.1 Pfizer 6.1.1 Pfizer Company Details 6.1.2 Pfizer Business Overview 6.1.3 Pfizer Liver Medicine Introduction 6.1.4 Pfizer Liver Medicine Revenue in United States Market (2016-2021) 6.1.5 Pfizer Recent Developments 6.2 Roche 6.2.1 Roche Company Details 6.2.2 Roche Business Overview 6.2.3 Roche Liver Medicine Introduction 6.2.4 Roche Liver Medicine Revenue in United States Market (2016-2021) 6.2.5 Roche Recent Developments 6.3 Sanofi 6.3.1 Sanofi Company Details 6.3.2 Sanofi Business Overview 6.3.3 Sanofi Liver Medicine Introduction 6.3.4 Sanofi Liver Medicine Revenue in United States Market (2016-2021) 6.3.5 Sanofi Recent Developments 6.4 Novartis 6.4.1 Novartis Company Details 6.4.2 Novartis Business Overview 6.4.3 Novartis Liver Medicine Introduction 6.4.4 Novartis Liver Medicine Revenue in United States Market (2016-2021) 6.4.5 Novartis Recent Developments 6.5 Amgen 6.5.1 Amgen Company Details 6.5.2 Amgen Business Overview 6.5.3 Amgen Liver Medicine Introduction 6.5.4 Amgen Liver Medicine Revenue in United States Market (2016-2021) 6.5.5 Amgen Recent Developments 6.6 Xiuzheng Pharmaceutical Group 6.6.1 Xiuzheng Pharmaceutical Group Company Details 6.6.2 Xiuzheng Pharmaceutical Group Business Overview 6.6.3 Xiuzheng Pharmaceutical Group Liver Medicine Introduction 6.6.4 Xiuzheng Pharmaceutical Group Liver Medicine Revenue in United States Market (2016-2021) 6.6.5 Xiuzheng Pharmaceutical Group Recent Developments 6.7 Xiaolin Zhiyao 6.7.1 Xiaolin Zhiyao Company Details 6.7.2 Xiaolin Zhiyao Business Overview 6.7.3 Xiaolin Zhiyao Liver Medicine Introduction 6.7.4 Xiaolin Zhiyao Liver Medicine Revenue in United States Market (2016-2021) 6.7.5 Xiaolin Zhiyao Recent Developments 6.8 Henan Lingrui Pharmaceutical 6.8.1 Henan Lingrui Pharmaceutical Company Details 6.8.2 Henan Lingrui Pharmaceutical Business Overview 6.8.3 Henan Lingrui Pharmaceutical Liver Medicine Introduction 6.8.4 Henan Lingrui Pharmaceutical Liver Medicine Revenue in United States Market (2016-2021) 6.8.5 Henan Lingrui Pharmaceutical Recent Developments 6.9 Kuihua yaoye 6.9.1 Kuihua yaoye Company Details 6.9.2 Kuihua yaoye Business Overview 6.9.3 Kuihua yaoye Liver Medicine Introduction 6.9.4 Kuihua yaoye Liver Medicine Revenue in United States Market (2016-2021) 6.9.5 Kuihua yaoye Recent Developments 6.10 Sanjiu Pharmaceutical 6.10.1 Sanjiu Pharmaceutical Company Details 6.10.2 Sanjiu Pharmaceutical Business Overview 6.10.3 Sanjiu Pharmaceutical Liver Medicine Introduction 6.10.4 Sanjiu Pharmaceutical Liver Medicine Revenue in United States Market (2016-2021) 6.10.5 Sanjiu Pharmaceutical Recent Developments 6.11 Harbin Pharmaceutical Group 6.11.1 Harbin Pharmaceutical Group Company Details 6.11.2 Harbin Pharmaceutical Group Business Overview 6.11.3 Harbin Pharmaceutical Group Liver Medicine Introduction 6.11.4 Harbin Pharmaceutical Group Liver Medicine Revenue in United States Market (2016-2021) 6.11.5 Harbin Pharmaceutical Group Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer
SummaryThis report contains market size and forecasts of Liver Medicine in United States, including the following market information: Table of Contents1 Introduction to Research & Analysis Reports1.1 Liver Medicine Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Liver Medicine Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Liver Medicine Overall Market Size 2.1 United States Liver Medicine Market Size: 2021 VS 2027 2.2 United States Liver Medicine Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Liver Medicine Players in United States Market 3.2 Top United States Liver Medicine Companies Ranked by Revenue 3.3 United States Liver Medicine Revenue by Companies 3.4 Top 3 and Top 5 Liver Medicine Companies in United States Market, by Revenue in 2020 3.5 Companies Liver Medicine Product Type 3.6 Tier 1, Tier 2 and Tier 3 Liver Medicine Players in United States Market 3.6.1 List of Tier 1 Liver Medicine Companies in United States 3.6.2 List of Tier 2 and Tier 3 Liver Medicine Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Liver Medicine Market Size Markets, 2021 & 2027 4.1.2 Tablet 4.1.3 Capsule 4.1.4 Oral Liquid 4.2 By Type - United States Liver Medicine Revenue & Forecasts 4.2.1 By Type - United States Liver Medicine Revenue, 2016-2021 4.2.2 By Type - United States Liver Medicine Revenue, 2022-2027 4.2.3 By Type - United States Liver Medicine Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Liver Medicine Market Size, 2021 & 2027 5.1.2 Hospital 5.1.3 Pharmacy 5.1.4 Others 5.2 By Application - United States Liver Medicine Revenue & Forecasts 5.2.1 By Application - United States Liver Medicine Revenue, 2016-2021 5.2.2 By Application - United States Liver Medicine Revenue, 2022-2027 5.2.3 By Application - United States Liver Medicine Revenue Market Share, 2016-2027 6 Liver Medicine Companies Profiles 6.1 Pfizer 6.1.1 Pfizer Company Details 6.1.2 Pfizer Business Overview 6.1.3 Pfizer Liver Medicine Introduction 6.1.4 Pfizer Liver Medicine Revenue in United States Market (2016-2021) 6.1.5 Pfizer Recent Developments 6.2 Roche 6.2.1 Roche Company Details 6.2.2 Roche Business Overview 6.2.3 Roche Liver Medicine Introduction 6.2.4 Roche Liver Medicine Revenue in United States Market (2016-2021) 6.2.5 Roche Recent Developments 6.3 Sanofi 6.3.1 Sanofi Company Details 6.3.2 Sanofi Business Overview 6.3.3 Sanofi Liver Medicine Introduction 6.3.4 Sanofi Liver Medicine Revenue in United States Market (2016-2021) 6.3.5 Sanofi Recent Developments 6.4 Novartis 6.4.1 Novartis Company Details 6.4.2 Novartis Business Overview 6.4.3 Novartis Liver Medicine Introduction 6.4.4 Novartis Liver Medicine Revenue in United States Market (2016-2021) 6.4.5 Novartis Recent Developments 6.5 Amgen 6.5.1 Amgen Company Details 6.5.2 Amgen Business Overview 6.5.3 Amgen Liver Medicine Introduction 6.5.4 Amgen Liver Medicine Revenue in United States Market (2016-2021) 6.5.5 Amgen Recent Developments 6.6 Xiuzheng Pharmaceutical Group 6.6.1 Xiuzheng Pharmaceutical Group Company Details 6.6.2 Xiuzheng Pharmaceutical Group Business Overview 6.6.3 Xiuzheng Pharmaceutical Group Liver Medicine Introduction 6.6.4 Xiuzheng Pharmaceutical Group Liver Medicine Revenue in United States Market (2016-2021) 6.6.5 Xiuzheng Pharmaceutical Group Recent Developments 6.7 Xiaolin Zhiyao 6.7.1 Xiaolin Zhiyao Company Details 6.7.2 Xiaolin Zhiyao Business Overview 6.7.3 Xiaolin Zhiyao Liver Medicine Introduction 6.7.4 Xiaolin Zhiyao Liver Medicine Revenue in United States Market (2016-2021) 6.7.5 Xiaolin Zhiyao Recent Developments 6.8 Henan Lingrui Pharmaceutical 6.8.1 Henan Lingrui Pharmaceutical Company Details 6.8.2 Henan Lingrui Pharmaceutical Business Overview 6.8.3 Henan Lingrui Pharmaceutical Liver Medicine Introduction 6.8.4 Henan Lingrui Pharmaceutical Liver Medicine Revenue in United States Market (2016-2021) 6.8.5 Henan Lingrui Pharmaceutical Recent Developments 6.9 Kuihua yaoye 6.9.1 Kuihua yaoye Company Details 6.9.2 Kuihua yaoye Business Overview 6.9.3 Kuihua yaoye Liver Medicine Introduction 6.9.4 Kuihua yaoye Liver Medicine Revenue in United States Market (2016-2021) 6.9.5 Kuihua yaoye Recent Developments 6.10 Sanjiu Pharmaceutical 6.10.1 Sanjiu Pharmaceutical Company Details 6.10.2 Sanjiu Pharmaceutical Business Overview 6.10.3 Sanjiu Pharmaceutical Liver Medicine Introduction 6.10.4 Sanjiu Pharmaceutical Liver Medicine Revenue in United States Market (2016-2021) 6.10.5 Sanjiu Pharmaceutical Recent Developments 6.11 Harbin Pharmaceutical Group 6.11.1 Harbin Pharmaceutical Group Company Details 6.11.2 Harbin Pharmaceutical Group Business Overview 6.11.3 Harbin Pharmaceutical Group Liver Medicine Introduction 6.11.4 Harbin Pharmaceutical Group Liver Medicine Revenue in United States Market (2016-2021) 6.11.5 Harbin Pharmaceutical Group Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(medicine)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|